The results of the present study revealed that VH032 plays a crucial role in antitumour effects on glioma cells in vitro by inhibiting the VHL/HIF-1α/VEGF signalling pathway and interfering with the proliferation, invasion, migration, apoptosis and cycle distribution of glioma cells. Here, HIF1A is linked to central nervous system cancer.